SCHEMBL8074703

SCHEMBL8074703

CCc1ccc(C(=O)c2ccc(F)c(F)c2)cc1CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.52
CES1 P23141 2/20 0.52
VNN1 O95497 5/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CHRNA1 P02708 1/20 0.41
CHRNG P07510 1/20 0.41
CHRNB1 P11230 1/20 0.41
CHRNB2 P17787 1/20 0.41
SLC6A2 P23975 1/20 0.41
CHRNB4 P30926 1/20 0.41
CHRNA3 P32297 1/20 0.41
CHRNA4 P43681 1/20 0.41
SLC6A3 Q01959 1/20 0.41
CHRND Q07001 1/20 0.41
CHRNA7 P36544 1/20 0.40
HSD17B14 Q9BPX1 1/20 0.39
RAB9A P51151 1/20 0.39
HSD17B1 P14061 1/20 0.39
HSD17B2 P37059 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10914230 0.87 SMN1; SMN2 (0.44) RAB9AHSD17B1
SCHEMBL4356098 0.85 CES2 (0.43) CES2CES1HSD17B14RAB9AHSD17B1
SCHEMBL8064210 0.84 LTA4H (0.48) CES2CES1RAB9A
SCHEMBL7967901 0.82 CES2 (0.73) CES2CES1VNN1MEN1KMT2A
SCHEMBL8074896 0.82 CES2 (0.42) CES2CES1RAB9AHSD17B1HSD17B2
SCHEMBL8079317 0.81 CES2 (0.44) CES2CES1RAB9A
SCHEMBL13664921 0.80 CES2 (0.53) CES2CES1VNN1MEN1KMT2A
SCHEMBL8079269 0.79 CES2 (0.52) CES2CES1MEN1KMT2ARAB9A
SCHEMBL28548204 0.79 LTA4H (0.47) CES2CES1RAB9AHSD17B1HSD17B2
SCHEMBL8074156 0.78 KMT2A (0.46) CES2CES1MEN1KMT2ASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6166072-A Amino acid derivatives ALLELIX NEUROSCIENCE, INC. (CA) 2000-12-26 US disclosed
WO-1999034790-A1 GLYCINE TRANSPORT INHIBITORS ALLELIX NEUROSCIENCE, INC. (US) 1999-07-15 WO disclosed